Ryzolt is the brand name for tramadol hydrochloride, an opioid painkiller that produces its analgesic effect through a metabolite called M1. Ryzolt addiction and abuse is a result of a centrally acting drug with a mode of action that is still under study, but that seems to bind to the opioid receptors and affect the reuptake of norepinephrine and serotonin. It is used to help manage moderate to moderately severe pain in adults.
Tramadol is a white, bitter crystalline powder that is available in tablet form containing 50mg of tramadol hydrochloride and being white in color. The drug is slow acting, with effects beginning about an hour after ingestion, and peaking after about two or three hours.
Ryzolt is often used for managing arthritis, back pain and chronic pain. When it is abused, it’s commonly abused by those with a prior history of drug addiction or drug abuse – usually those with an addiction to opioids or painkillers, or with a common addiction such as to alcohol. Moreover, as a prescription drug, it is potentially available to teens and adolescents, many of whom are more likely to abuse prescription drugs under the mistaken belief that they’re “safe”. For this reason it’s essential to monitor teens for sings of Ryzolt addiction and abuse.
While Ryzolt prescriptions peaked in 2012, the drug appears to be less commonly prescribed and hopefully less commonly abused. This, however does raise the concern that users may be turning to other drugs in its place.
Common Street Names for Ryzolt
Ryzolt may be known by some of the other brand names under which Tramadol is marketed, including Ultram, Conzip, Ultram ER and Rybix ODT.
Ryzolt and its generic name Tramadol were placed into Schedule IV of the Controlled Substances Act in 2014, indicating that they are considered to have low potential for abuse, an accepted use in medical treatment; they also have some risk of physical or psychological dependence.
History and Trends in Ryzolt Addiction and Abuse
Tramadol, the generic name for Ryzolt, is a relatively young drug, having been created in Germany in 1962. Ryzolt was first approved by the FDA in 1995 under the trade name ULTRAM, with generic, combination and extended release tablets subsequently approved. Ryzolt prescriptions in the US reached 37.3 million in 2012.
Side effects of Ryzolt
Ryzolt is intended as a painkiller, and analgesia is its primary side effect. However, there are a number of additional symptoms that users may experience. These include dizziness, sleepiness, nausea, constipation and sweating; it may also reduce blood pressure. Unlike opioids such as morphine, Ryzolt does not cause a slowing of the heart rate or breathing.
When used in combination with opioids and alcohol, however, Ryzolt may exacerbate the symptoms of these drugs, creating a depression of the central nervous system and respiratory system. This can potentially lead to overdose, which may manifest as a comatose state, or possibly even death.
Some users have experienced seizures when using Ryzolt, even when taking the medication as prescribed. The risk of seizures increases when individuals take the drug at higher than prescribed ranges. Seizures are also more likely if an individual is taking other opioids or is taking antidepressant medication, or if they have a history of seizures or epilepsy.
An allergic reaction to the drug is also possible, although this usually occurs with the first dose.
Withdrawal symptoms of Ryzolt
Ryzolt addiction can present in withdrawal symptoms when an individual suddenly stops taking the drug. Common withdrawal symptoms of Ryzolt include anxiety, sweating, insomnia, muscle pain, nausea, tremors and shakes, gastrointestinal issues, sinus problems and sometimes hallucinations.
Some individuals may experience panic attacks and severe anxiety; for this reason it is recommended that usage is not stopped abruptly, but rather is tapered off under medical supervision. Ryzolt may also cause life-threatening withdrawal symptoms in newborns.
reatment for Ryzolt Addiction and Abuse
Ryzolt abuse can lead to physical, psychological and social problems, and users may begin seeking harder pain killers. Attempting to break a Ryzolt addiction without help can be challenging, especially given the danger of abruptly discontinuing the use of the drug.
An in-patient or intensive detoxification can help someone recover from Ryzolt addiction by providing a safe and structured space where they can be weaned off the drug, manage their withdrawal symptoms, and explore the underlying issues that may have led to their addiction. In-house programs also allow the creation of new habits, routines and relationships, providing individuals with a relapse prevention plan upon graduating to out-patient or aftercare programs.
If you or someone you know is struggling with ryzolt addiction and abuse, get help now. Contact White Sands Tampa about our ryzolt addiction treatment programs today at 1-877-640-7820.